Globe Life (GL)
NYSEFinancialsInsurance - LifeSnapshot 2026-07-07
$176.73-0.14%
Close 2026-07-07 · 1-day change
Reading GL? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track GL free→NYSEFinancialsInsurance - LifeSnapshot 2026-07-07
Reading GL? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track GL free→Globe Life grows earnings with EPS guidance raised to about $15.65 for 2026. Life insurance net sales rose 6% in Q1, showing steady demand. The company actively buys back shares, repurchasing 1.4 million in Q1. Profit margins remain stable with a low valuation compared to peers.
Recent earnings misses and a guidance cut show risks to growth. Executive stock sales may signal weaker management confidence. The insurance market could face margin pressure and slower sales growth.
The price is about 9% below our fair value near $193, reflecting roughly 8% revenue growth expected by analysts. Our fair value is above the Street median, indicating some upside if growth and margins hold.
Breaks if: EPS guidance falls below $15.40 for FY26
Globe Life aims to increase its full-year 2026 earnings guidance to a range of $15.40 to $15.90 per share.
Stated in 3 of last 3 quarters. EPS guidance increased from a midpoint of $14.9 in 2025-Q3 to $15.65 in 2026-Q1. The trajectory is delivering on the stated priority with consistent upward revisions.
Standing thesis, reviewed periodically — not a price target or advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“The Company also increased full-year 2026 earnings guidance to a range of $15.40 to $15.90.”
“Globe Life projects net operating income between $14.95 to $15.65 per diluted common share for the year ending December 31, 2026.”
“For the year ending December 31, 2026, we estimate that net operating income per share will be in the range of $14.60 to $15.30.”
Breaks if: Life and health net sales growth falls below 6% YoY
Globe Life focuses on increasing net sales in both life and health insurance segments.
Stated in 2 of last 2 quarters. Life net sales increased 6% in 2026-Q1, following an 11% increase in 2025-Q4. The focus on growing net sales in life and health segments is delivering results, with consistent growth observed.
“Life net sales grew at each division, resulting in a 6% increase in total life net sales.”
“Net sales of life insurance increased 11% for the quarter, and net health sales increased 71%.”
Breaks if: Share repurchases fall below 1.4 million shares per quarter
Globe Life continues its share repurchase program, buying back 1.4 million shares in the latest quarter.
Stated in 2 of last 2 quarters. 1.4 million shares repurchased in 2026-Q1, following 1.3 million in 2025-Q4. The share repurchase program is actively progressing, aligning with management's capital allocation strategy.
“1.4 million shares of Globe Life Inc. common stock were repurchased during the quarter.”
“1.3 million shares of Globe Life Inc. common stock were repurchased during the quarter.”
Breaks if: PE ratio rises above 16.55 and stays elevated